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#Aaron Diamond AIDS Research Center Chemokine receptors are seven transmembrane (7tm)
Rockefeller University domain, G protein–coupled molecules that mediate the
New York, New York 10016 chemotaxis of T cells and phagocytic cells to areas
of inflammation (Power and Wells, 1996). While CCR5
expression appears to be largely restricted to cells of
the hematopoietic lineage (Alkhatib et al., 1996; DengSummary
et al., 1996; Samson et al., 1996), Fusin is expressed on
a wide variety of CD4-positive and -negative cells inSeveral members of the chemokine receptor family
a number of tissues including brain, lung, and spleenhave been shown to function in association with CD4
(Federsppiel et al., 1993; Loetscher et al., 1994). Thus,to permit HIV-1 entry and infection. However, the
during the course of HIV-1 infection, changes in themechanism by which these molecules serve as CD4-
utilization of particular cofactors may enable viruses toassociated cofactors is unclear. In the present report,
infect an increasing number of CD4-positive target cells.we show that one member of this family, termed Fusin/
However, while the utilization of these molecules follow-CXCR4, is able to function as an alternative receptor
ing CD4 binding is likely to have an important role infor some isolates of HIV-2 in the absence of CD4. This
determining the tropism of particular viral isolates, theconclusion is supported by the finding that (1) CD4-
mechanism by which chemokine receptors interact withindependent infection by these viruses is inhibited by
CD4 and the viral envelope glycoprotein during infectionan anti-Fusin monoclonal antibody, (2) Fusin expres-
is unclear. While it has been hypothesized that the enve-sion renders human and nonhuman CD4-negative cell
lope glycoprotein may associate with one or more oflines sensitive to HIV-2-induced syncytium induction
these 7tm proteins following CD4 binding (Choe et al.,and/or infection, and (3) Fusin is selectively down-
1996; Deng et al., 1996; Doranz et al., 1996; Feng et al.,regulated from the cell surface following HIV-2 infec-
1996), a direct interaction between these molecules hastion. The finding that one chemokine receptor can
not been shown.function as a primary viral receptor strongly suggests
In addition to studies of CD4-dependent infection,that the HIV envelope glycoprotein contains a binding
several reports have shown that some HIV isolates cansite for these proteins and that differences in the affin-
ity and/or the availability of this site can extend the infect lymphoid (Clapham et al., 1992; McKnight et al.,
1994) and nonlymphoid cells (Tateno et al., 1989; Ikeuchihost range of these viruses to include a number of
CD4-negative cell types. et al., 1990; Harouse et al., 1991; Clapham et al., 1992)
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in the absence of CD4. These studies are likely to be 12G5, a Monoclonal Antibody That Inhibits
CD4-Independent Infection by HIV-2relevant to increasing evidence in humans (Wiley et al.,
1986; Moses et al., 1993; Bagasra et al., 1996; Living- In an effort to analyze interactions between cellular mol-
ecules and viral envelope glycoproteins, an anti-cellularstone et al., 1996) and nonhuman primates (Mankowski
et al., 1994; Dean et al., 1996) that CD4-negative cells MAb termed 12G5 was derived that was able to inhibit
syncytium induction by HIV-2/vcp on CD4-negative cellcan be targets for HIV infection in vivo. In general HIV
infection of CD4-negative cells proceeds slowly and lines (see Experimental Procedures and Figure 2A). This
MAb also inhibited syncytium induction by CP-MAC, awithout cytopathic effects, most likely indicating the rel-
atively inefficient use of an alternative receptor. Such is biological variant of SIVmac that has been shown to be
highly infectious and fusogenic for Sup-T1 cells in athe case for the glycolipid galactosylceramide, which
can serve as an alternative receptor on human glial and CD4-dependent manner (LaBranche et al., 1994) (Figure
2A). 12G5 was shown by FACS analysis to react withcolon carcinoma cell lines (Harouse et al., 1991). How-
ever, particularly for some isolates of HIV-2, infection of several CD4-positive and -negative human hematopoi-
etic cell lines (Table 1) and with unfractionated humanCD4-negative cells can occur rapidly and with extensive
cell fusion (Clapham et al., 1992). The highly cytopathic peripheral blood lymphocytes (not shown). Reactivity
was also seen with some nonhematopoietic human cellnature of these infections has suggested that these iso-
lates are able to utilize one or more alternative receptors lines including HeLa (cervical carcinoma) and RD (rhab-
domyosarcoma), but not HOS (osteosarcoma) or U87with high efficiency. However, the identity of these re-
ceptors has remained unknown. (glial) cells (Table 1). No reactivity was seen on the mu-
rine myeloma line SP2 or the other nonhuman cell linesIn the present study, we show that isolates of HIV-2
that are able to infect a number of CD4-negative cells shown in Table 1.
In addition to inhibiting cell fusion, 12G5 also neutral-utilize the HIV-1 cofactor, Fusin, as a primary receptor in
the absence of CD4. We show that the highly cytopathic, ized infection by HIV-2/vcp and CP-MAC when preincu-
bated with appropriate target cells. CP-MAC infectionCD4-independent infection exhibited by these viruses
is inhibited by a novel monoclonal antibody to Fusin and of Sup-T1 cells was readily inhibited by antibody con-
centrations of 1 mg/ml while somewhat higher concen-that the introduction of Fusin alone into a variety of
human and nonhuman CD4-negative cells renders them trations (5–20 mg/ml) were required to inhibit HIV-2/vcp
infection of CD4-negative lines including BC7, Nalm6,fully permissive for HIV-2-induced syncytium induction
and infection. We also show that the cloned HIV-2 env and Daudi (Figure 2B). Infection of these cell types was
not inhibited by IgG2a monoclonal antibodies that weregene induced syncytium formation of nonhuman cells
that expressed Fusin in the absence of CD4. Finally, as isotype matched for 12G5 (not shown). Although 12G5
frequently caused cell clumping (Figure 2A), no inhibi-described for numerous viral receptors, we demonstrate
that Fusin is selectively down-regulated from the cell tory effects were seen on cell growth and notoxic effects
were apparent when cells were cultured in antibodysurface following infection by these HIV-2 isolates.
These findings strongly suggest that the HIV envelope concentrations as high as 50 mg/ml (not shown).
12G5 also inhibited two other HIV-2 isolates, HIV-2/glycoprotein contains a binding site for chemokine re-
ceptor proteins and that differences in the affinity and/ Rod-A and HIV-2/Rod-B, that have been shown to in-
duce fusion on CD4-negative cell lines including Daudior the availability of this site can markedly extend the
host range of these viruses to include a number of CD4- and RD (Clapham et al., 1992). HIV-2/Rod-A infectivity
has been shown to be enhanced by preincubation withnegative cell types.
soluble CD4 (sCD4) while HIV-2/Rod-B induces syncytia
on these CD4-negative cells without sCD4. As shownResults
in Table 2, 12G5 inhibited cell fusion at concentrations
$5 mg/ml when H9 cells chronically infected by HIV-Derivation of an HIV-2 Variant That Infects
Cells in the Absence of CD4 2/Rod-A or /Rod-B were cultured in the presence or
absence of sCD4, respectively. Inhibition was also seenTo study receptors involved in CD4-independent infec-
tion, a biological variant of HIV-2, termed HIV-2/vcp, of another HIV-2 isolate, HIV-2/CBL-23 that induces syn-
cytia on RD cells following preincubation with sCD4was derived from the HIV-2/NIH-z isolate (Zagury et al.,
1988) (see Figure 1). HIV-2/vcp was shown to infect a (Table 2) (Clapham et al., 1992). Therefore, in addition
to its anti-viral effects on CP-MAC and HIV-2/vcp, 12G5number of CD4-negative lymphoid cell lines of T- (BC7,
HSB, CEMss42) and B- (Daudi and Nalm6) cell origin inhibited infection and/or cell fusion for two other geneti-
cally distinct isolates of HIV-2 on CD4-negative target(Figure 1A) as well as the nonlymphoid rhabdomyosar-
coma line RD (not shown). As expected, no infection cells.
was seen when these cell types were inoculated with
the T cell line–tropic isolate HIV-1/LAI (Figure 1A). In
MAb 12G5 Reacts with Fusinaddition, anti-CD4 monoclonal antibodies (MAbs) were
Although 12G5 was shown to react with the cell surfacenot able to inhibit infection of BC7 (Figure 1B), Daudi or
by FACS, efforts to immunoprecipitate or immunoblotNalm6 cells (not shown), or cell-to-cell fusion between
the antigen under a variety of conditions were unsuc-HIV-2/vcp-infected cells and uninfected BC7 cells (Fig-
cessful. However, following the identification of Fusin asure 1C). Similar to other HIV-2 isolates that can infect
a CD4-associated accessory factor for T cell line–tropicCD4-negative cells (Clapham et al., 1992), HIV-2/vcp
HIV-1 isolates (Feng et al., 1996), we evaluated 12G5 forinfected the majority of these cell types with extensive
reactivity with this protein. U87 cells that stably ex-cell fusion and killing, indicating the highly efficient use
of one or more alternative receptors (not shown). pressed either Fusin or the CC-chemokine receptor,
HIV/CD4-Independent Entry/Chemokine Receptors
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Figure 1. Infection of CD4 Negative Cells by HIV-2/vcp
(A) Cell lines were inoculated with cell-free HIV-2/vcp or HIV-1/LAI and monitored for RT activity in culture supernatant at the indicated time
points. Except for Sup-T1, all cell lines were shown to be CD4-negative as determined by FACS analysis using a panel of anti-CD4 MAbs
and/or by Western blot using an anti-CD4 serum.
(B) Failure of an anti-CD4 MAb to inhibit HIV-2/vcp infection of a CD4-negative line. BC7 or Sup-T1 cells were inoculated with either HIV-2/
vcp or HIV-1/LAI, respectively, in the presence or absence of anti-CD4 MAb #19. Cells were maintained in the presence of the anti-CD4 MAb
for 8 days at which time RT activity was determined. Similar results were seen using the anti-CD4 MAb OKT4A (not shown).
(C) Syncytium induction assays were performed on the indicated target cells by cocultivation with HIV-2/vcp-infected BC7 cells or HIV-1/LAI-
infected Hut-78 cells in the presence or absence of 10 mg/ml of anti-CD4 MAb #19. Cultures were photographed after either 24 or 48 hr for
assays involving HIV-1/LAI or HIV-2/vcp, respectively. As shown, extensive syncytium formation is induced by HIV-2/vcp on CD4 negative
BC7 cells and is unaffected by the anti-CD4 MAb.
CCR1, were derived and evaluated by FACS for 12G5 cells transduced with the control vector alone (Figure
3A). Similar results were seen for human 293T cells inbinding. Remarkably, 12G5 reacted strongly with U87
cells that expressed Fusin while only background stain- which Fusin was transiently expressed by transfection
(not shown).ing was detected on U87 cells that expressed CCR1 or
Cell
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Figure 2. Inhibition of CP-MAC and HIV-2/vcp Syncytium Induction and Infection by the 12G5 MAb
(A) Sup-T1 cells or CD4-negative BC7, Nalm6, and Daudi cells were preincubated with the concentrations of 12G5 indicated, inoculated with
the viruses shown, and serially monitored for RT activity in culture supernatants as described in Experimental Procedures. Dose-dependent
inhibition of CP-MAC and HIV-2/vcp infection by 12G5 is shown.
(B) Sup-T1 or BC7 cells were cultured with either CP-MAC-infected Sup-T1 cells, or HIV-2/vcp-infected BC7 cells in the presence or absence
of 12G5 (10 mg/ml) and photographed after 48 hr. Inhibition of syncytium formation by 12G5 is seen for both viruses.
To determine if 12G5 reacted with other chemokine Analysis of Fusin-expressing CHO cells was also per-
formed by immunofluorescence confocal microscopy ofreceptor family members, a panel of CHO cell lines was
used that stably expressed either Fusin, CC-chemokine intact cells. As shown in Figure 3C, staining was ob-
served on cells expressing HA-tagged Fusin while noreceptors (CCR1, CCR2b, CCR3, CCR4, or CCR5), or
CXC-chemokine receptors (IL8R-A or IL8R-B). The re- reactivity was seen with cells expressing HA-tagged
IL8R-B receptors. Expression of each protein could becombinant receptors in these CHO lines were expressed
either untagged or tagged at the amino terminus with the detected using an HA-specific MAb, and no staining
was observed with an anti-CD4 MAb used as a controlinfluenza hemagglutinin (HA) epitope. Surface binding
assays were performed using 125I-labeled 12G5 and (Figure 3C). Similar negative results were seen when
CHO cells expressing other chemokine receptors in-showed specific binding only to cells that expressed
Fusin (Figure 3B). Scatchard analysis of 12G5 binding cluding, IL8R-A, CCR1, CCR2b, CCR3, CCR4, and CCR5
were stained with 12G5 (not shown). Intracellular Fusinon CHO cells expressing HA-tagged Fusin or to RD or
BC7 cells showed approximately 106, 4 3 105, and 5 3 was also detectable by 12G5 on cells permeabilized with
saponin (not shown). Therefore, 12G5 bound specifically104 antibody molecules bound per cell, respectively,
with Kds of 1–5 nM (not shown). to both human and nonhuman cells that expressed re-
HIV/CD4-Independent Entry/Chemokine Receptors
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Table 1. Reactivity of 12G5 Monoclonal Antibody with Different Cell Lines
Cell Line Species/Origin 12G5 Reactivity CD4
Sup-T1 Human/T cell 1 1
Hut-78 Human/T cell 1 1
CEMss Human/T cell 1 1
Molt4 clone 8 Human/T cell 1 1
HSB Human/T cell 1 2
BC7 Human/T cell 1 2
CEMss42 Human/T cell 1 2
CEMx174 Human/TxB hybrid 1 1
Daudi Human/B cell 1 2
Nalm6 Human/B cell 1 2
KM3.79 Human/B cell 1 2
REH Human/B cell 1 2
RD Human/rhabdomyosarcoma 1 2
Hela Human/cervical carcinoma 1 2
HOS Human/osteosarcoma 2 2
U87 Human/astrocyte, glial 2 2
CCCS1L2 Feline/kidney 2 2
QT6-5 Quail/fibrosarcoma 2 2
CHO Hamster/ovary 2 2
SP2 Murine/B cell 2 2
Cells were stained for FACS analysis with saturating amounts of 12G5 (10–15 mg/ml). Reactivity was compared to an isotype-matched control
MAb. A panel of anti-CD4 MAbs was used to evaluate CD4 expression including OKT4, OKT4A, and #19. Plus sign indicates reactivity $3-
fold background. CEMss42 cells are a CD4-negative variant of CEMss derived by serially panning with an anti-CD4 MAb, sorting for CD4-
negative cells and cloning by limiting dilution. BC7 cells were cloned by limiting dilution from a culture of Sup-T1 cells chronically infected
by HIV-1/NL4-3 and show no detectable HIV-1, as determined by p24 production, coculture assay with susceptible cells, and PCR of genomic
DNA with virus-specific primers (M. J. E. and J. A. H., unpublished). Lysates of BC7 and CEMss42 exhibit no detectable CD4 protein by
Western blot using a rabbit anti-CD4 antiserum.
combinant Fusin, strongly suggesting that this antibody 12G5 by FACS analysis (Table 1) and have no detectable
reacts specifically with the human Fusin protein. Fusin mRNA (Feng et al., 1996; A. McKnight et al., sub-
mitted). As shown (Figure 4A), when Fusin-expressing
U87 cells were cocultured with HIV-2/vcp-infected BC7
Fusin Serves as an Alternative Receptor cells, extensive cell fusion was seen. Preincubatingcells
for HIV-2/vcp in the Absence of CD4 with 12G5 (10 mg/ml) completely abolished syncytium
Because 12G5 was able to inhibit CD4-independent in- formation. No fusion was seen when similar cocultures
fection by some HIV-2 isolates, the above findings sug- were performed with nontransduced U87 cells or with
gested that Fusin was functioning as an alternative re- U87 cells that expressed only recombinant CD4 (Figure
ceptor for these viruses. In order to test this hypothesis, 4A). Similar results were seen for murine NIH 3T3 fibro-
U87 cells that stably expressed either recombinant Fusin blast cells that stably expressed Fusin in the absence
or CD4 were evaluated in coculture assays for their abil- of CD4 (not shown).
ity to form syncytia with HIV-2/vcp-infected cells. As Experiments were performed to determine if recombi-
previously noted, U87 cells exhibited no reactivity with nant Fusin could mediate productive infection by cell-
free HIV-2/vcp. Control U87 cells or U87 cells that stably
expressed either Fusin or CD4 were incubated with HIV-
Table 2. Inhibition of HIV-2 Syncytium Induction by 12G5 on 2/vcp and monitored for infection by serial determina-
CD4-Negative Cell Linesa tion of reverse transcriptase activity in the culture super-
natants. As shown (Figure 4B), viral replication wasHIV-2-Infected Cellb Target Cellc
detectable only on U87 cells that expressed Fusin and
Cell/Virus RD Daudi
was associated with extensive cytopathic effects includ-
H9/HIV-2 Rod-B 2.5 5.0 ing syncytium formation and cell killing (not shown).
H9/HIV-2 Rod-A plus sCD4 5.0 5.0 Finally, in order to evaluate the function of the HIV-2/
H9/HIV-2 CBL-23 plus sCD4 5.0 5.0
vcp envelope glycoprotein in the absence of other viral
a CD4-negative RD orDaudi cells were treated for 30 min with varying gene products, the HIV-2/vcp env gene was PCR ampli-
concentrations of 12G5 before adding an equal number of H9 cells fied from genomic DNA, cloned and expressed in HeLa
chronically infected with the HIV-2 isolate indicated. Cultures were
cells, and cell-to-cell fusion quantitated as previouslymaintained at 378C overnight before counting the number of syn-
described using a luciferase gene reporter assay (Dor-cytia.
anz et al., 1996). Quail QT6 target cells were transfectedb Where indicated, infected cells were preincubated with sCD4 (1
mg/ml) at 378C for 60 min. with a luciferase reporter gene and either Fusin alone
c Numbers indicate the minimum antibody concentration (mg/ml) or Fusin with CD4. As shown (Figure 5), the HIV-2/vcp
that inhibited syncytium formation by .95%.
envelope glycoprotein fused with Fusin-expressing tar-
Cell
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Figure 3. Reactivity of 12G5 with Fusin
(A) U87 cells stably expressing either Fusin,
CCR1, or the control vector (pBABE-puro)
(Deng et al., 1996) were evaluated for reactiv-
ity with 12G5 (10 mg/ml) by FACS. The region
for positivity, designated M1, was defined us-
ing a control MAb and the percentage of cells
falling within this window for each sample
indicated.
(B) Control CHO cells or cells stably express-
ing HA-tagged or untagged Fusin or the other
chemokine receptors indicated were evalu-
ated for reactivity to [125I]12G5 or [125I]12CA5
(anti-HA), using protocols described pre-
viously (Pelchen-Matthews et al., 1989).
Scatchard-type analysis indicated that the Kd
for 12G5 binding on CHO-Fusin cells was 1–5
nM; [125I]12G5 binding was competed close
to background levels by 100 nM 12G5 but
was not influenced by the anti-HA antibody
12CA5 (data not shown).
(C) Immunofluorescence confocal micros-
copy of CHO cells stably expressing Fusin
or chemokine receptors using 12G5. CHO-
K1 cells expressing HA-tagged Fusin or the
human IL8R-B receptor were stained with
12G5, the anti-human CD4 MAb Q4120, or an
antibody against the HA-tag (12CA5). Scale
bar 5 20 mm.
get cells in thepresence and absence of CD4. In contrast Down-Regulation of Surface Fusin
by HIV-2/vcp Infectiona comparably expressed BH8 envelope glycoprotein de-
rived from a T cell line–tropic HIV-1 induced fusion on Cellular receptors for enveloped viruses are characteris-
tically down-regulated from the cell surface followingFusin-expressing cells only in the presence of CD4. No
fusion was seen when HIV-2/vcp env-expressing cells productive infection, rendering infected cells resistant to
superinfection by viruses that utilize the same receptorwere cultured with QT6 cells transfected with the IL8R-
B receptor or the expression vector alone (Figure 5). (Weiss, 1993). Indeed, the observation that CD4 was
selectively down-regulated on HIV-1-infected cells pro-Taken together, these results show that Fusin can serve
as an alternative receptor for some isolates of HIV-2 in vided the initial evidence that CD4 was a receptor for
this virus (McDougal et al., 1986). Down-regulation ofthe absence of CD4 on human as well as nonhuman
target cells. These findings also demonstrate that for CD4 and other viral receptors by envelope glycoproteins
has been attributed to the formation of intracellular com-HIV-2/vcp, CD4 alone is not sufficient to permit viral
entry and indicate that the utilization of Fusin is an oblig- plexes between envelope molecules and the cellular
receptors and/or to the blocking of binding sites onatory step for this virus during infection.
HIV/CD4-Independent Entry/Chemokine Receptors
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Figure 5. Induction of Cell Fusion by the HIV-2/vcp Envelope Glyco-
protein in a Gene Reporter Fusion Assay
HeLa effector cells were transfected with pCR3.1 expressing either
HIV-2/vcp env or BH8 HIV-1 env clones and infected with vaccinia.
QT6 target cells were transfected with constructs expressing Fusin,
IL8R-B or the pCR3.1 expression vector alone, and a plasmid con-
taining the luciferase gene driven by a T7 promoter (Promega).
Where indicated target cells were also infected with pT4, which
constitutively expresses CD4 from the CMV promoter. Luciferase
activity as an indication of cell fusion is indicated in terms of relative
light units (RLU) as described previously (Doranz et al., 1996).
marked and selective reduction in 12G5 binding. Al-
though this experiment could not distinguish between
the loss of surface Fusin and blocking of the 12G5 epi-
tope, this result is entirelyconsistent with other evidence
noted above that Fusin is serving as a primary viral
receptor for HIV-2/vcp. As expected, CD4 was down-
regulated 95% and 98% on HIV-2/vcp and CP-MAC-Figure 4. Recombinant Fusin Is Sufficient to Render U87 Cells Sus-
infected Sup-T1 cells, respectively (not shown). Interest-ceptible to HIV-2/vcp Syncytium Induction and Infection
ingly, although Fusin was also down-regulated 75% on(A) Syncytium induction assays. U87 cells stably expressing either
HIV-2/vcp-infected Sup-T1 cells, no reduction in 12G5Fusin or CD4, or untransduced cells (control) were cocultured with
HIV-2/vcp-infected BC7 cells and photographed for syncytium for- reactivity was seen on Sup-T1 cells that were infected
mation as described in Experimental Procedures. Large syncytia are by CP-MAC (Figure 6) or HIV-1/LAI (not shown). Because
evident only in U87 cells expressing Fusin, and this was completely CP-MAC (LaBranche et al., 1994) and HIV-1/LAI are de-
inhibited by preincubating cells with 12G5 (10 mg/ml). (B) Infection
pendent on CD4, this finding indicates that Fusin down-assays. Cells were inoculated with cell-free HIV-2/vcp (1,000 TCID50
regulation occurs when it isutilized as a primary receptorunits) and serial determination of RT activity performed at the indi-
in the absence of CD4 but not as a CD4-associatedcated time points. Infection is only seen for Fusin-expressing cells.
Extensive syncytium formation and cell killing were also observed coreceptor (see Discussion).
in this culture that correlated with the time of RT production (data
not shown). Discussion
In this report we demonstrate that Fusin, the recently
receptors that are expressed on the cell surface (Hoxie described cofactor for T cell line–adapted isolates of
et al., 1986; Crise et al., 1990; Schneider-Schaulies et HIV-1, is able to function as an alternative receptor for
al., 1995). Given the evidence that Fusin was serving as some isolates of HIV-2 in the absence of CD4. Two
a primary receptor for HIV-2/vcp, we utilized 12G5, to genetically distinct isolates of HIV-2 that exhibited CD4-
determine if this molecule was down-regulated during independent infection of human lymphoid and non-
HIV-2/vcp infection. lymphoid cells (HIV-2/vcp and HIV-2/Rod-B) were inhib-
BC7, Daudi, and Nalm6 cells that were either unin- ited in virus neutralization and/or syncytium induction
fected or chronically infected by HIV-2/vcp were evalu- assays by 12G5, a MAb shown to be specific for Fusin.
ated for Fusin expression by FACS analysis with 12G5. In addition, U87 cells that were resistant to HIV-2/vcp
As shown in Figure 6, on HIV-2/vcp-infected cells, 12G5 became fully permissive for syncytium formation and
binding was reduced 98%, 79%, and 87% compared to infection following transduction with recombinant Fusin
uninfected cells. In contrast, no reduction was seen in in the absence of CD4. This effect was completely de-
expression of HLA class I or transferrin receptors using pendent on the viral envelope glycoprotein, since a
specific MAbs (not shown). Thus, for several CD4-nega- cloned HIV-2/vcp env gene mediated syncytium forma-
tion on QT6 cells when Fusin was expressed withouttive lymphoid cells, HIV-2/vcp infection produced a
Cell
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Figure 6. Downregulation of Fusin Expression by HIV-2/vcp Infection
Cell lines that were either uninfected or infected by the viruses indicated were evaluated for surface reactivity by FACS either with an isotype-
matched control MAb or 12G5 (10 mg/ml), and the mean channel fluorescence intensity (MCF) shown for each cell type. Cells were 100%
infected, as determined by immunofluorescence microscopy using an HIV-2/SIVmac p27gag -specific MAb. Loss of 12G5 reactivity is seen
on HIV-2/vcp-infected but not CP-MAC-infected cells. The data are representative of three experiments from two separate infections.
CD4. Finally, as is the case for many viral receptors, HIV- infection, it is not down-regulated by CP-MAC, a virus
that still requires CD4 for infection and cell fusion (Figure2/vcp infection produced a selective down-regulation of
Fusin from the cell surface. 6). Recent studies have also shown that HIV-1/LAI,
which requires Fusin in association with CD4 to infectAlthough several members of the chemokine receptor
family have been shown to function in association with cells, induces minimal (<10%) down-regulation of sur-
face Fusin on chronically infected cells (J. A. H., unpub-CD4 to permit viral entry (Alkhatib et al., 1996; Choe et
al., 1996; Deng et al., 1996; Doranz et al., 1996; Dragic lished data). If the ability of HIV-2/vcp to utilize Fusin as
an alternative receptor corresponds to a higher affinityet al., 1996; Feng et al., 1996), the precise mechanism
of action of these proteins as coreceptors has not been interaction with the envelope glycoprotein, it follows that
the transport of Fusin to the cell surface during synthesisestablished. One recent report mapped a determinant
for coreceptor utilization to the hypervariable V3 loop could be inhibited in infected cells as has been shown
to occur for CD4 (Crise et al., 1990; Jabbar and Nayak,of the gp120 surface envelope glycoprotein (Choe et
al., 1996). Additional studies using chimeric receptors 1990; Koga et al., 1990). In contrast, for viruses that
might bind more weakly to Fusin (i.e., in a CD4-depen-between CCR5 and CCR2b have identified regions on
CCR5 that are required for this protein to function as a dent manner) an intracellular interaction could either fail
to occur or not be sufficiently stable to interfere withCD4 coreceptor for M- and dual-tropic HIV-1 isolates
(Rucker et al., 1996). These findings are consistent with the surface expression of Fusin. Viruses such as HIV-2/
vcp and HIV-2/Rod-B will be particularly useful in bio-the view that an initial interaction of the envelope glyco-
protein with CD4 produces a conformational change chemical assays to evaluate direct interactions of their
envelope glycoproteins with Fusin and perhaps otherthat facilitates a secondary interaction with one or more
7tm proteins (Deng et al., 1996; Doranz et al., 1996). members of the chemokine receptor family.
Although in general, HIV and SIV isolates are CD4-However, it is also possible that 7tm proteins facilitate
viral entry indirectly by affecting the cell membrane and/ dependent, our finding that two genetically distinct iso-
lates of HIV-2 can infect Fusin-expressing cells indepen-or CD4 without contacting the viral envelope molecule
(Berson et al., 1996; Choe et al., 1996). Our finding, that dent of CD4 indicates that this property is not restricted
to a single laboratory variant. Indeed, as initially re-at least one member of this family can serve as a primary
receptor in the absence of CD4 for a subset of HIV-2 ported, HIV-2s with only a minimal passage history have
exhibited CD4-independence in vitro (Clapham et al.,isolates, strongly suggests that these proteins interact
directly with the viral envelope glycoprotein during entry. 1992). While the relevance of this finding for pathogene-
sis, if any, remains to be determined, it is possible thatMoreover, the finding that a chemokine receptor, unlike
CD4, can be both necessary and sufficient for viral entry, the ability of some HIV isolates to utilize a 7tm molecule
as a primary receptor could have implications for patho-raises the intriguing possibility that these 7tm proteins
may be primordial receptors for the primate lentiviruses. genesis. Studies of tissues from HIV-infected humans
(Wiley et al., 1986; Bagasra et al., 1996; Livingstone etThus, the role of CD4 may simply be to direct the viral
envelope glycoprotein onto these molecules where the al., 1996; Moses et al., 1993) and SIV-infected nonhuman
primates in advanced stages of disease (Mankowskisubsequent fusion reaction then occurs.
It remains to be determined what changes in the enve- et al., 1994; Dean et al., 1996) have shown productive
infection of cells that are apparently CD4-negative. Al-lope glycoprotein enable the HIV-2 variants that we have
analyzed to bypass a requirement for CD4. Recent stud- though it is possible that these cells do express a low
level of CD4, our study raises the possibility that HIVies of HIV-2/Rod-B have indicated that mutations in both
gp120 as well as TM are required for this virus to infect could evolve in vivo to bypass CD4 and utilize at least
some chemokine receptors directly to infect cells. GivenCD4-negative cells (Reeves and Schulz, 1996). These
mutations could increase exposure of a binding site the expanding number of molecules that are part of the
chemokine receptor family (Power and Wells, 1996), andfor a 7tm protein and/or increase the affinity of this
interaction. Interestingly, although Fusin is down-regu- the ability of HIV isolates (Feng et al., 1996; Alkhatib et
al., 1996; Dragic et al., 1996; Deng et al., 1996; Doranzlated by HIV-2/vcp in the context of CD4-independent
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described previously (Hoxie et al., 1986, 1988; LaBranche et al.,et al., 1996; Choe et al., 1996) to interact with different
1994). CD4-negative T lymphoid lines HSB and CEMss42 were pro-members of this family, it is possible that direct, CD4-
vided by David Weiner (University of Pennsylvania) and Carolynindependent interactions between envelope molecules
Doyle (Duke University), respectively, and BC7 was derived from
and 7tm proteins could occur in vivo on a variety of Sup-T1 cells, as described in Table 1. Human B cell lines, Nalm6,
cell types in the immune, hematopoietic, or nervous KM3.79, and REH were provided by Lyn Healy and Mel Greaves.
Hela, RD, and Daudi cells have been described previously (Claphamsystems. By broadening the viral host range and/or
et al., 1991, 1992). 293T and CCCS1L2 cells were provided bycausing alterations in cellular functions, such interac-
Michael Malim (University of Pennsylvania); QT6-5 Japanese quailtions could be highly relevant to clinical complications
fibrosarcoma cells were provided by Paul Bates (University of Penn-of AIDS.
sylvania), and murine myeloma SP2 cells and the W6/32 hybridoma
Understanding the mechanisms through which HIV cell line were obtained from the American Type Culture Collection.
and SIV utilize 7tmmolecules, either directlyor in associ- U87 cells stably expressing recombinant Fusin, CCR1, or CD4 were
derived as described previously (Deng et al., 1996). Murine NIH 3T3ation with CD4, will provide considerable insight into
cells expressing either Fusin alone or Fusin and human CD4 werethe molecular basis for differences in tropism among
provided by D. Littman (New York University) (Deng et al., 1996).these viruses. However, it is clear that coreceptor utiliza-
Chinese Hamster Ovary cells (CHO-K1) expressing HA-tagged ortion is structurally complex and that a single envelope
untagged human chemokine receptors were derived using cDNAs
glycoprotein can interact with genetically divergent derived by RT–PCR and cloned into pcDNA1neo for expression in
members of the chemokine receptor family (Choe et al., mammalian cells (Power et al., 1995). Stable CHO lines expressing
the chemokine receptors were derived by screening for reactivity1996; Doranz et al., 1996). Moreover, recent studies with
to the anti-HA MAb, 12CA5. The receptor selectivity of the HA-12G5 have shown that the ability of this antibody to
tagged receptor lines was tested by radioligand binding assaysinhibit T-tropic isolates of HIV-1 is highly dependent on
using membranes purified from the respective cells. No significantthe viral isolate and the target cell (A. McKnight et al.,
differences in ligand binding properties were seen between tagged
submitted). This finding has suggested (1) that other and nontagged receptors (T. N. C. W., unpublished data).
cofactors in addition to Fusin are involved on particular
cell types; (2) that post translational modifications occur Viruses
An uncloned viral stock of HIV-2/NIH-z was provided by R. Gallo.on Fusin that are relevant to its interaction with the
HIV-2/vcp was derived from HIV-2/NIH-z (Zagury et al., 1988) byenvelope glycoprotein and 12G5; and/or (3) that viruses
passaging virus first onto CP-MAC infected Sup-T1 cells that hadmay utilize different epitopes on Fusin, only some of
completely down-regulated their surface expression of CD4 (La-
which are blocked by 12G5. Even thoughCP-MAC infec- Branche et al., 1994), and then onto BC7 cells. Sequence analysis
tion of Sup-T1 cells is inhibited by 12G5, this virus is of the HIV-2/vcp env gene amplified from genomic DNA showed
unable to infect or fuse with several T cell lines that no evidence of recombination in env with CP-MAC. CP-MAC was
derived as previously described from the SIVmac molecular clone,coexpress high levels of CD4 and Fusin, including
BK28 (LaBranche et al., 1994). Additional variants of HIV-2 describedCEMx174 and HUT-78 cells (LaBranche et al., 1994,
for their ability to infect CD4-negative cells included HIV-2/CBL-23,1995). Thus, still other molecules may be required as
HIV-2/Rod-A, and HIV-2/Rod-B (Clapham et al., 1992).
cofactors and determinants of tropism for some HIV and
SIV isolates. Constructs
The availability of 12G5, which reacts with cell surface The HIV-2/vcp env gene was PCR amplified from genomic DNA from
HIV-2/vcp-infected HSB cells using the primer pair 59-GGCTCAas well as intracellular Fusin, provides an important re-
TCCGGTCGACGAATCAGACAAGTGAGTATGAAGGGTAGTAAG-39agent for basic studies of this receptor at the cellular
and 59-CTGCTGATATCGCTGTCCCTCACAGGAGGGCGAG-39, andlevel including (1) its association with CD4 and other
cloned into the eukaryotic expression vector pCR3.1 (Invitrogen).surface molecules, (2) its distribution within tissues and
The BH8 env clone was provided by Dr. Pat Earl (NIH). Fusin and
among subsets of hematopoietic cells, and (3) its partici- CD4 were expressed as previously described (Berson et al., 1996;
pation in cellular signal transduction pathways. We re- Doranz et al., 1996). Frank Jirik (University of British Columbia) pro-
vided the IL8 receptor clone.cently utilized 12G5 to demonstrate rapid internalization
of Fusin on lymphoid cells in response to phorbol esters
Antibodies(J. A. H. and M. M., unpublished data), a property origi-
12G5 was produced by inoculating Balb/c mice with 107 living CP-nally predicted for CD4-associated cellular cofactors
MAC-infected Sup-T1 cells intraperitoneally for 3 weekly injections,
of HIV-1 (Golding et al., 1994, 1995). Finally, because and fusion protocols were performedas described previously (Brass
interaction of 7tmG protein–coupled receptors with their et al., 1994). Hybridomas were screened in 96-well plates for the
natural ligands frequently induces their internalization ability to inhibit CP-MAC-induced syncytium induction on Sup-T1
cells and cloned by limiting dilution. Antibody was purified from(von Zastrow and Kobilka, 1992; Hoxie etal., 1993; Grady
ascites using HiTrap Protein G (Pharmacia Biotech). The anti-CD4et al., 1995), 12G5 may also be useful in evaluating the
MAb #19 was produced using a similar protocol in which the immu-effects of physiologic ligands and potential agonists for
nizing cell type was uninfected Sup-T1 cells (J. A. H. and M. A.,
this receptor. Future studies with this antibody should unpublished data). Specificity of this antibody for CD4 was deter-
provide important insights into the structure of Fusin mined by its ability to detect the 55 kDa CD4 protein by Western
and help to identify domains involved in its physiologic blot from lysates of CD4-positive cells (data not shown). The anti-
CD4 MAbs OKT4A and OKT4 were purchased from Ortho Pharma-role as a signal transduction molecule and in its patho-
ceuticals, and 12CA5 was purchased from Boehringer-Mannheim.logic role as a receptor for HIV.
D47 is an IgG2a MAb reactive with the HIV-1/LAI gp120. Rabbit anti-
human CD4 serum was provided by R. Sweet (SmithKline Beecham).
Experimental Procedures
Viral Infection and Neutralization Assays
Viral infection assays on lymphoid cell lines and U87 cells expressingCells
CD4-positive human T lymphoidcell lines, Sup-T1, Hut-78, H9, CEM, recombinant Fusin or CD4, were performed as previously described
by inoculating cultures with 1000 TCID50 units of either HIV-1/LAI orMolt4-clone8, and the TxB cell hybrid line CEMx174 have been
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HIV-2/vcp. Input virus was washed out after 24 hr and cultures Tate, E. Whitehorn, and R. Barrett; and helpful discussions with M.
Malim, S. Talbot, and R. Weiss. J. A. H. is a Fellow of Carter-Wallace,were monitored for infection by serial determinations of reverse
transcriptase activity and visual inspection for syncytium formation. Inc. This work was supported by grants from the National Institutes
of Health to J. A. H., N. R. L., and R. W. D.; from the Medical ResearchFor neutralization assays, target cells were preincubated with vary-
ing concentrations of either 12G5 or anti-CD4 MAbs for 30 min at Council, UK to M. M., A. M., and P. R. C.; and from the North Atlantic
Treaty Organization to M. M. and J. A. H. Correspondence and378C followed by the addition of 100 TCID50 units of virus, as titered
on each target cell. Input virus was removed after 24 hr and cultures requests for materials should be addressed to J. A. H. (e-mail: hoxie
@mail.med.upenn.edu).were monitored for infection as above. Cells were maintained in the
presence of antibody for the duration of the experiment.
Received September 6, 1996; revised October 21, 1996.
Cell Fusion Assays
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